Jack Barchas

Q: What Schools Are Affiliated With Jack Barchas

Jack Barchas is affiliated with the following schools: Weill Cornell Medicine, University of California, Los Angeles, Stanford University, Cornell University, University of California, San Francisco, Pomona College

Jack Barchas's AcademicInfluence.com Rankings

Jack Barchas

Biology

#4032

World Rank

#6074

Historical Rank

#1575

USA Rank

biology Degrees

Download Badge

Biology

Jack Barchas's Degrees

Doctorate Medicine University of California, San Francisco
PhD Psychiatry University of California, San Francisco

Why Is Jack Barchas Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jack David Barchas is an American psychiatrist who is the Barklie McKee Henry Professor and Chairman of the Department of Psychiatry at the Weill Cornell Medical College of Cornell University and the Psychiatrist-in-Chief of the New York-Presbyterian Hospital/Weill Cornell Medical Center and the Payne Whitney Psychiatric Clinic. He was formerly the Nancy Friend Pritzker professor in psychiatry at Stanford University and dean of research and neuroscience at the University of California, Los Angeles School of Medicine.

(See a Problem?)

Jack Barchas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (2013) (2011)
Amplified RNA synthesized from limited quantities of heterogeneous cDNA. (1990) (1312)
Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder (2017) (998)
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 (2011) (929)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) (676)
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion (1986) (672)
Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat (1977) (556)
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
Circadian patterns of gene expression in the human brain and disruption in major depressive disorder (2013) (464)
Evidence for two separate opiate peptide neuronal systems (1978) (415)
Adrenocorticotropin in rat brain: immunocytochemical localization in cells and axons. (1978) (330)
Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression (2010) (311)
Behavioral neurochemistry: neuroregulators and behavioral states. (1978) (311)
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry (2009) (304)
Long-term stress-induced analgesia and activation of the opiate system. (1981) (257)
Catecholamine secretion as a function of perceived coping self-efficacy. (1985) (255)
BRAIN AMINES: RESPONSE TO PHYSIOLOGICAL STRESS. (1963) (230)
beta-Lipotropin: localization of cells and axons in rat brain by immunocytochemistry. (1977) (224)
Immunocytochemical localization of methionine enkephalin: preliminary observations. (1977) (222)
Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions (1982) (219)
Inhibition of transmethylations of biogenic amines by S-adenosylhomocysteine. Enhancement of transmethylation by adenosylhomocysteinase. (1971) (218)
Acute Pharmacology of Melatonin (1967) (210)
Epinephrine, norepinephrine, dopamine and serotonin: Differential effects of acute and chronic stress on regional brain amines (1982) (208)
Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder (2015) (206)
Enkephalin-like material elevated in ventricular cerebrospinal fluid of pain patients after analgetic focal stimulation H. Akil, D.E. Richardson, J. Hughes and J.D. Barchas, Science, 201 (1978) 463–465 (1978) (199)
Serotonin and behavior (1973) (191)
Epinephrine and Norepinephrine Responses in Continuously Collected Human Plasma to a Series of Stressors (1983) (178)
Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats. (1980) (170)
Appearance of beta-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation. (1978) (165)
Constitutively expressed rat mRNA encoding a 70-kilodalton heat-shock-like protein (1985) (161)
CSF monoamine metabolites in depression and schizophrenia. (1980) (158)
Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) (154)
Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects. (1978) (153)
Corticosterone: a critical factor in an opioid form of stress-induced analgesia. (1982) (146)
Choline in tardive dyskinesia and Huntington's disease. (1976) (143)
"Hypersexuality" and Behavioral Changes in Cats Caused by Administration of p-Chlorophenylalanine (1970) (141)
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder (2014) (140)
Parachlorophenylalanine and habituation to repetitive auditory startle stimuli in rats. (1970) (139)
Catecholamines, dopamine, and endorphin levels during extreme exercise. (1981) (138)
Determination of tryptophan and metabolites in rat brain and pineal tissue by reversed-phase high-performance liquid chromatography with electrochemical detection. (1980) (129)
III. Determination of plasma catecholamines and free 3, 4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection (1981) (126)
Post-mortem molecular profiling of three psychiatric disorders (2016) (122)
Simultaneous determination of indole- and catecholamines in tissues using a weak cation-exchange resin. (1972) (121)
Simultaneous determination of catecholamines and unconjugated 3,4-dihydroxyphenylacetic acid in brain tissue by ion-pairing reverse-phase high-performance liquid chromatography with electrochemical detection. (1980) (116)
In situ transcription: specific synthesis of complementary DNA in fixed tissue sections. (1988) (114)
Distribution of gastrin releasing peptide-bombesin-like immunostaining in rat brain (1982) (114)
Brain norepinephrine metabolism and shock-induced fighting behavior in rats: differential effects of shock and fighting on the neurochemical response to a common footshock stimulus. (1974) (112)
Influence of maternal proximity on behavioral and physiological responses to separation in infant rhesus monkeys (Macaca mulatta). (1990) (109)
Teacher-delivered resilience-focused intervention in schools with traumatized children following the second Lebanon War. (2011) (108)
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. (2013) (107)
B-ETA-Endorphin immunoreactivity in rat and human blood: radioimmunoassay, comparative levels and physiological alterations. (1979) (107)
Binding of 3H-beta-endorphin to rat brain membranes: characterization of opiate properties and interaction with ACTH. (1980) (106)
In situ hybridization : applications to neurobiology (1987) (105)
Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients. (1975) (104)
Neuroendocrine and neurochemical measurements in depression. (1981) (103)
Reciprocal day/night relationship between serotonin oxidation and N-acetylation products in the rat pineal gland. (1983) (100)
The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
Narcolepsy: biogenic amine deficits in an animal model. (1983) (98)
Some observations on the opiate peptides and schizophrenia. (1979) (97)
Enzymatic Synthesis of Adrenaline in Mammalian Brain (1969) (95)
Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia (2020) (94)
AGE AND ENZYME ACTIVITY IN THE HUMAN PINEAL. (1964) (94)
β-Endorphin and Schizophrenia (1980) (87)
Chaotic behavior in dopamine neurodynamics. (1984) (83)
Catecholamines: strain differences in biosynthetic enzyme activity in mice. (1972) (83)
Multiple endogenous ligands for opioid receptors (1983) (79)
Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder (2015) (79)
Cross tolerance between morphine and the long-term analgesic reaction to inescapable shock (1981) (77)
Distribution of neuropeptide K-immunoreactivity in the rat central nervous system (1986) (75)
Narcolepsy: cholinergic receptor changes in an animal model. (1984) (74)
Evidence for alterations of the glial syncytial function in major depressive disorder. (2016) (73)
Simultaneous determination of indole- and catecholamines in small brain regions in the rat using a weak cation exchange resin (1976) (73)
Antibodies Specific for α‐N‐Acetyl‐β‐Endorphins: Radioimmunoassays and Detection of Acetylated β‐Endorphins in Pituitary Extracts (1982) (71)
Small cell carcinoma cell lines contain opioid peptides and receptors (1986) (71)
Regional distribution and developmental change of tryptophan hydroxylase activity in rat brain 1 (1972) (65)
Dopamine synthesis in rat brain striatal synaptosomes. II. Dibutyryl cyclic adenosine 3':5'-monophosphoric acid and 6-methyltetrahydropterine-induced synthesis increases without an increase in endogenous dopamine release. (1976) (65)
Distribution of norepinephrine, epinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic acid in dog brain (1982) (65)
Facilitated shock-induced aggression following antidepressive medication in the rat (1975) (65)
Neuropeptides in neurologic and psychiatric disease. (1986) (65)
Blood pressure elevation in rats by peripheral administration of TyrGlyPheMetArgPhe and the invertebrate neuropeptide, PheMetArgPheNH2 (1982) (63)
Identification of gastrin releasing peptide-related substances in guinea pig and rat brain. (1983) (61)
Brain serotonin and pituitary-adrenal function. (1973) (60)
Tryptoline formation by a preparation from brain with 5-methyltetrahydrofolic acid and tryptamine. (1975) (60)
Tryptoline inhibition of serotonin uptake in rat forebrain homogenates. (1976) (59)
Tryptolines. Formation from tryptamines and 5-MTHF by human platelets. (1974) (56)
G protein-linked signaling pathways in bipolar and major depressive disorders (2013) (55)
Tyrosine hydroxylase: studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase. (1981) (54)
Central epinergic inhibition of corticosterone release in rat. (1981) (53)
Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia (1983) (52)
Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis (2018) (52)
ENKEPHALIN-LIKE MATERIAL IN NORMAL HUMAN CSF: MEASUREMENT AND LEVELS. (1978) (50)
The effect of parachlorophenylalanine (PCPA) on shock-induced fighting behavior in rats. (1970) (50)
The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. (2016) (50)
Phospholipid-induced activation of tyrosine hydroxylase from rat brain striatal synaptosomes. (1976) (50)
Tyrosine Hydroxylase from Bovine Striatum: Catalytic Properties of the Phosphorylated and Nonphosphorylated Forms of the Purified Enzyme (1982) (48)
Colocalization of α-Neo-endorphin and dynorphin immunoreactivity in hypothalamic neurons (1981) (48)
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation. (1975) (48)
Platelet monoamine oxidase in chronic schizophrenic patients. (1978) (47)
LOCALIZATION OF MELATONIN IN THE NERVOUS SYSTEM * (1964) (47)
The effects of naloxone in chronic schizophrenia. (1981) (46)
Characteristics of the inhibition of aromatic l-amino acid decarboxylase by α-methylamino acids (1963) (46)
In vitro degradation of enkephalin: evidence for cleavage at the Gly-Phe bond. (1978) (46)
Interaction of opiate peptide and noradrenalin systems: Light microscopic studies (1980) (45)
Biological rhythms and mental disorders (1988) (45)
Acetylated and nonacetylated forms of β-endorphin in rat brain and pituitary (1981) (44)
Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid. (1979) (44)
Human sleep-electroencephalogram: a damped oscillatory phenomenon. (1972) (43)
Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection. (1981) (43)
Fibroblast growth factor 9 is a novel modulator of negative affect (2015) (42)
Cholinergic involvement in mental disorders. (1978) (42)
Brain distributions of α-neo-endorphin and β-neo-endorphin: Evidence for regional processing differences (1982) (42)
Gradients of biogenic amine metabolites in cerebrospinal fluid. (1975) (41)
Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine. (1982) (40)
Widespread Periodic Intrinsic Connections in the Tree Shrew Visual Cortex (2005) (39)
Mitochondrial Mutations in Subjects with Psychiatric Disorders (2015) (39)
Genetic variation in activity of enzymes involved in synthesis of catecholamines. (1972) (38)
General psychiatry. (1998) (38)
Enkephalinase: Selective inhibitors and partial characterization (1980) (38)
Characterization of endorphins from the pituitary of the Spiny Dogfish Squalus acanthias (1986) (38)
The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome (1976) (38)
Measurement of Methionine‐Enkephalin [Arg6,Phe7] in Rat Brain by Specific Radioimmunoassay Directed at Methionine Sulphoxide Enkephalin[Arg6,Phe7] (1982) (37)
Altered choroid plexus gene expression in major depressive disorder (2014) (37)
THE EFFECTS OF 5‐HYDROXYTRYPTOPHAN AND 5‐HYDROXYTRYPTAMINE ON DOPAMINE SYNTHESIS AND RELEASE IN RAT BRAIN STRIATAL SYNAPTOSOMES 1 (1978) (37)
Endorphins, beta-LPH, and ACTH: biochemical, pharmacological and anatomical studies. (1978) (37)
Dissociation of long-term analgesia and the shuttle box escape deficit caused by inescapable shock. (1982) (36)
Dopamine synthesis in rat brain striatal synaptosomes. I. Correlations between veratridine-induced synthesis stimulation and endogenous dopamine release. (1976) (36)
Brain striatal tyrosine hydroxylase: activation of the enzyme by cyclic AMP-independent phosphorylation. (1979) (36)
Sexual Behavior of Male Cats after Administration of Parachlorophenylalanine (1970) (36)
Stereotyped hyperactivity in rats treated with tranylcypromine and specific inhibitors of 5-HT reuptake. (1976) (35)
Brain norepinephrine: Enhanced turnover after rubidium treatment (1970) (35)
Opioid peptides in human plasma: evidence for multiple forms. (1982) (35)
Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence (2017) (35)
Epinephrine formation and metabolism in mammalian brain. (1969) (34)
A genetic analysis of aggressive behavior in two strains of mice (1977) (34)
MONOAMINE METABOLITES IN CSF IN PSYCHIATRIC DISORDERS (1979) (34)
Brain Norepinephrine: Enhanced Turnover after Rubidium Treatment (1970) (34)
Immunohistochemical localization of dynorphin (1-8) in hypothalamic magnocellular neurons: evidence for absence of proenkephalin. (1982) (34)
Fused silica capillary gas chromatography/negative chemical ionization mass spectrometry for determination of catecholamines and their O-methylated metabolites (1982) (34)
Psychopharmacology : from theory to practice (1977) (34)
Tyrosine hydroxylase activity in rat brain following “REM” sleep deprivation (1973) (34)
BIOLOGICAL BASIS OF SUBSTANCE ABUSE (1993) (34)
Serotonin and schizophrenia: Correlations between serotonergic activity and schizophrenic motor behavior (1985) (33)
A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism. (1974) (33)
A primate analogue of amphetamine-induced behaviors in humans. (1981) (33)
Evidence for Transcriptional Factor Dysregulation in the Dorsal Raphe Nucleus of Patients with Major Depressive Disorder (2012) (33)
Thermal Denaturation of Native Striatal Tyrosine Hydroxylase: Increased Thermolability of the Phosphorylated Form of the Enzyme (1981) (33)
CSF amine metabolites and depression (1987) (32)
Naloxone blocks amphetamine-induced rearing: Potential interaction between catecholamines and endorphins (1978) (31)
Experimental ethanol ingestion: sleep variables and metabolites of dopamine and serotonin in the cerebrospinal fluid. (1975) (31)
Social environment and brain biogenic amine metabolism in rats. (1974) (31)
Clinical application of the probenecid test for measurement of monoamine turnover in the CNS. (1981) (31)
Regulation of dopamine synthesis in rat brain striatal synaptosomes. (1975) (31)
Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome. (1978) (30)
Stimulation of synaptosomal dopamine synthesis by veratridine (1974) (29)
Met‐Enkephalin [Arg6,Phe7] Immunoreactivity in Bovine Caudate and Bovine Adrenal Medulla (1982) (28)
The effects of ethanol ingestion on cyclic AMP, homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid. (1976) (28)
Biochemical Hypotheses of Mood and Anxiety Disorders (1999) (28)
Serotonin and pituitary-adrenal function (1974) (28)
Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs (1988) (28)
Potentiation by cocaine of the stimulus-induced increase in dopamine synthesis in rat brain striatal synaptosomes (1977) (26)
Isolation and characterization of substance P, substance P 5–11, and substance K from two metastatic ileal carcinoids (1985) (26)
Effect of benzodiazepine compounds on brain amine metabolism. (1975) (26)
Levels of pro-neo-endorphin/dynorphin-derived peptides in the hypothalamo-posterior pituitary system of male and female Brattleboro rats (1983) (26)
Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs (1982) (26)
Behavioral pharmacology of the endorphins. (1982) (26)
Isolation and characterization of α-N-acetylβ-endorphin(1–26) from the rat posterior/intermediate pituitary lobe (1981) (25)
CSF Monoamine Metabolites in Movement Disorders and Normal Aging (1985) (25)
Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population (2011) (25)
Neuroregulators and sleep mechanisms. (1975) (25)
A gas-liquid chromatographic assay of melatonin and indoleamines using heptafluorobutyryl derivatives. (1972) (24)
Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation (2009) (23)
Effect of p-chlorophenylalanine on hydroxylation of tryptophan in pineal and brain of rats. (1972) (22)
In situ hybridization in neurobiology : advances in methodology (1994) (22)
Genome-wide association study identifies 30 loci associated with bipolar disorder (2019) (22)
Genetic determination of aggressive behavior and brain cyclic AMP. (1975) (21)
Blood pressure elevation in rats by peripheral administration of Tyr-Gly-Gly-Phe-Met-Arg-Phe and the invertebrate neuropeptide, Phe-Met-Arg-Phe-NH2. (1982) (21)
Theoretical Psychopathology: An Application of Dynamical Systems Theory to Human Behavior (1983) (20)
Opiates and classical conditioning: selective abolition of conditioned responses by activation of opiate receptors within the central nervous system. (1982) (20)
Regulation of adrenal phenylethanolamine N-methyltransferase activity in three inbred mouse strains. (1972) (20)
Compensatory hypertrophy and phenylethanolamine N-methyl transferase (PNMT) activity in the rat adrenal. (1969) (20)
In vitro phosphorylation of a purified preparation of bovine corpus striatal tyrosine hydroxylase. (1978) (20)
Human EEG response to beta-endorphin (1979) (19)
Rubidium-induced increase in shock-elicited aggression in rats (2004) (19)
Adrenal epinephrine and phenylethanolamine N-methyl transferase (PNMT) activity in the rat bearing a transplantable pituitary tumor. (1968) (19)
Analysis of peptides in tissue and plasma. Use of silicic acid extraction and reversed-phase columns for rapid purification prior to radioimmunoassay. (1982) (19)
Psychiatric and neurologic aspects of war: an overview and perspective (2010) (18)
Difficulties in comparing catecholamine-related enzymes from the brains of schizophrenics and controls. (1978) (18)
Biogenic Amines and Behavior (1972) (18)
Plasma concentrations of choline in man following choline chloride. (1978) (17)
Negative-ion mass spectrometry fused-silica capillary gas chromatography of neurotransmitters and related compounds. (1983) (17)
19F magnetic resonance imaging and spectroscopy of a fluorinated neuroleptic ligand: In vivo and in vitro studies (1988) (17)
α‐N‐Acetyl β‐Endorphins in the Pituitary: Immunohistochemical Localization Using Antibodies Raised Against Dynorphin(1‐13) (1981) (16)
Naloxone administration in chronic hallucinating schizophrenic patients (1979) (16)
Tyrosine hydroxylase activation. Comparison of in vitro phosphorylation and in vivo administration of haloperidol. (1982) (15)
Genetic differences in mechanisms involving neuroregulators. (1974) (15)
Gastrin-releasing peptide immunoreactivity in intestinal carcinoids. (1984) (15)
Catastrophe theory of dopaminergic transmission: a revised dopamine hypothesis of schizophrenia. (1981) (15)
Monoamine Hypotheses of Mood Disorders (1999) (15)
Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary. (1988) (15)
Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders (2019) (15)
Effect of p-chlorophenylalanine on tryptophan hydroxylase in rat pineal. (1972) (15)
Measurement of Total Opioid Peptides in Rat Brain and Pituitary by Radioimmunoassay Directed at the α‐N‐Acetyl Derivative (1983) (15)
Candidate Opioid Peptides for Interaction with the Immune System (1986) (15)
Cat brain amine content during sleep. (1973) (15)
Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders (2016) (15)
Sleep variables, cyclic AMP and biogenic amine metabolites after one day of ethanol ingestion. (1980) (15)
Influence of social setting on the induction of brain cyclic AMP in response to electric shock in the rat (1976) (14)
Immunohistochemical and biochemical studies of the enkephalins, β-endorphin, and related peptides (1979) (14)
Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for rat dopamine beta-hydroxylase. (1983) (14)
COMPARATIVE STUDIES ON THE EFFECT OF PARACHLOROPHENYLALANINE ON HYDROXYLATION OF TRYPTOPHAN IN PINEAL AND BRAIN OF RAT (1973) (14)
Rapid Increase of Phenylethanolamine N-Methyltransferase by Environmental Stress in an Inbred Mouse Strain (1972) (14)
Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641 — comparison with other brain amines (1985) (14)
Epinephrine Metabolism in Mammalian Brain after Intravenous and Intraventricular Administration (1969) (14)
The indoleamine hypothesis of depression: an overview and pilot study. (1977) (13)
Sleep and serotonin in two strains of Mus musculus. (1973) (13)
Neurochemistry of dopamine in Huntington's dementia and normal aging. (1986) (13)
The enzymatic formation of methanol from S-adenosylmethionine by various tissues of the rat. (1972) (13)
Opioid peptides as neuroregulators: Potential areas for the study of genetic-behavioral mechanisms (1982) (13)
Regional interactions of opioid peptides at μ and δ sites in rat brain (1983) (13)
In vivo intraneuronal MAO inhibition in rat brain SKF 64139, comparison to other potent PNMT inhibitors. (1981) (12)
A selective ion monitoring assay for probenecid. (1978) (12)
Connective Tissue Growth Factor Is a Novel Prodepressant (2018) (12)
Studies on the inhibition of actinomycin biosynthesis by D-valine. (1967) (12)
TRH stimulation test and depression (1987) (11)
ELECTROPHORETIC STUDY OF 5‐HYDROXYTRYPTOPHAN DECARBOXYLASE FROM BRAIN AND LIVER IN SEVERAL SPECIES (1974) (11)
STUDIES OF β‐ENDORPHIN IN PSYCHIATRIC PATIENTS * (1982) (11)
Cerebrospinal fluid epinephrine concentrations: discrimination of subtypes of depression and schizophrenia. (1984) (11)
Perspectives in psychopharmacology : a collection of papers in honor of Earl Usdin (1988) (11)
CSF phenylacetic acid and hostility in paranoid schizophrenia (1989) (11)
Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations (2018) (11)
Overtraining reduces morphine abolition of classically conditioned responses (1983) (11)
Investigating opioid peptides in schizophrenia and depression. (1986) (11)
Neurochemical studies in a mouse teratoma with neuroepithelial differentiation. Presence of cyclic AMP, serotonin and enzymes of the serotonergic, adrenergic and cholinergic systems (1976) (11)
Clinical studies on the role of endorphins in schizophrenia. (1981) (11)
Tryptolines: artifact or reality? A new method of analysis using GC/MS. (1982) (10)
JAMA and editorial independence. (1999) (10)
Modulation of activity of the striatal dopaminergic system during the hibernation cycle (1987) (10)
Taming effects of p-chlorophenylalanine on the aggressive behavior of septal rats (1976) (10)
N5,10-methylenetetrahydrofolate reductase activity in autopsied brain parts of chronic schizophrenics and controls and in vitro tryptoline formation. (1978) (10)
Histofluorescence in the unperfused CNS by cryostat and glyoxylic acid: a preliminary report. (1975) (9)
REM sleep eye movement activity and CSF concentrations of 5-hydroxyindoleacetic acid in psychiatric patients (1983) (9)
Coding SNPs included in exon arrays for the study of psychiatric disorders (2008) (9)
Catecholamines : basic and clinical frontiers : proceedings of the Fourth International Catecholamine Symposium, Pacific Grove, California, September 17-22, 1978 (1979) (9)
Central and peripheral contributions to hypothalamic epinephrine (1981) (9)
Particle-induced desorption mass spectrometry with a quadrupole mass spectrometer (1984) (9)
Catecholamine histofluorescence using cryostat sectioning and glyoxylic acid in unperfused frozen brain: a detailed description of the technique (1977) (9)
Neural differentiation in the OTT-6050 mouse teratoma: Enzymatic and immunofluorescence characterization of a tumor fraction showing melanogenesis in neuroepithelial cells (2004) (9)
The ultimate stigma: inadequate funding for research on mental illness and addictive disorders. (1985) (9)
TYROSINE HYDROXYLASE FROM BRAIN: PHOSPHORYLATION OF THE ENZYME BY CYCLIC AMP-DEPENDENT PROTEIN KINASE (1979) (9)
Deuterated peptides: Platinum catalyzed exchange labeling of leucine enkephalin and related peptides (1983) (8)
Platelet methylene reductase activity in schizophrenia. (1977) (8)
Opioid agonists and antagonists in schizophrenia. (1980) (8)
Alkali metal cations: Effects on isolation-induced aggression in the mouse (1977) (8)
Effects of melatonin and related compounds on the release of glycerol from rat adipose tissue in vitro. (1966) (8)
Effect of maternal manipulation on phenylethanolamine N-methyltransferase activity and corticosterone content of fetal adrenal gland. (1974) (8)
Enzyme activity in sleep and sleep deprivation (1975) (7)
Peptide neuroregulators: the opioid system as a model. (1985) (7)
Genetic aspects of catecholamine synthesis. (1975) (7)
In situ hybridization (1987) (7)
Abolition of conditioned heart-rate responses in rabbits following central administration of [N-MePhe3, D-Pro4] morphiceptin (1983) (7)
Identification of potential blood biomarkers associated with suicide in major depressive disorder (2022) (7)
Effects of chlorpromazine on sleep in cats pretreated with para-chlorophenylalanine. (1973) (7)
The role of serotonin in the regulation of a phasic event of rapid eye movement sleep: the ponto-geniculo-occipital wave. (1974) (7)
Isolation of enzyme cDNA clones by enzyme immunodetection assay: isolation of a peptide acetyltransferase. (1987) (6)
ENKEPHALINASE: PRELIMINARY CHARACTERIZATION AND COMPARISON WITH ANGIOTENSIN CONVERTING ENZYME (1980) (6)
Perspectives on depression—past, present, future a (2015) (6)
Induction of hepatic tyrosine aminotransferase by indole amines. (1971) (6)
Hallucinations and dreaming. (1970) (6)
Neuroregulators: neurotransmitters and neuromodulators (1979) (6)
Retraction of (1989) (6)
The tryptolines: Effect of intraventricular administration on spontaneous motor activity of rats (1976) (6)
Changes in rat hypothalamic and brain stem catecholamine concentrations following acute administration of phenylethanolamine-N-methyltransferase inhibitors (1980) (6)
Chiral analysis of urinary 5-hydroxymethtryptoline: implications for endogenous biosynthesis and formation during ethanol intoxication. (1985) (6)
Simultaneous Determination of 5-Hydroxytryptamine and Catecholamines in Tissues Using a Weak Cation Exchange Resin, (1972) (6)
Inference of Cell Type Composition from Human Brain Transcriptomic Datasets Illuminates the Effects of Age, Manner of Death, Dissection, and Psychiatric Diagnosis (2016) (6)
Cholinergic Dysfunction in Mania and Movement Disorders (1978) (6)
Electrophysiological evaluation of extracellular spermine and alkaline pH on synaptic human GABAA receptors (2019) (6)
Changing concepts about neuroregulation: neurotransmitters and neuromodulators (1980) (6)
Hypothalamic catecholamine changes under acute stress occur independently of nicotinic stimulation (1982) (5)
Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF. (1977) (5)
S-adenosylmethionine-dependent N-methyltransferase activity in autopsied brain parts of chronic schizophrenics and controls. (1978) (5)
Mass spectrometric identification and selected ion monitoring quantitation of gamma-amino-butyric acid (GABA) in human lumbar cerebrospinal fluid. (1978) (5)
Aaron Lerner: perspectives and lessons learned from the melatonin days. (2007) (5)
CHARACTERIZATION OF 3H-β-ENDORPHIN BINDING IN RAT BRAIN (1980) (5)
Immunohistochemical distribution of dynorphin B in rat brain : Relation to dynorphin A and a-neo-endorphin systems ( opioid peptides / pro-dynorphin / immunofluorescence / colocalization ) (5)
Antibodies to enkephalins: coupling of antigens and a specific methionine-enkephalin radioimmunoassay. (1977) (5)
Particle-induced desorption mass spectrometry with a quadrupole GC/MS instrument (1983) (5)
Regulatory properties of tyrosine hydroxylase: multiple forms, subunit structure and cyclic nucleotide independent phosphorylation (1981) (4)
Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders. (2016) (4)
Regional interactions of opioid peptides at mu and delta sites in rat brain. (1983) (4)
Studies on the relation of melatonin to sleep. (1968) (4)
Dopamine beta-hydroxylase rat mRNA: structure, regulation, and tissue localization. (1983) (4)
Synthetic N-dimethyl β-endorphin, a stabilized opioid peptide (1981) (4)
Pharmacologic studies of beta-endorphin in psychopathology. (1983) (4)
Retraction: CSF monoamine metabolites in movement disorders and normal aging. (1989) (4)
The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings]. (1979) (4)
Stereotypy and hyperactivity in rats receiving ethanol and a monoamine oxidase inhibitor (1977) (4)
Genetic aspects of monoamine mechanisms. (1974) (4)
Neuroregulators and Schizophrenia: A Look at the Dopamine and Endorphin Hypotheses (1984) (4)
A national plan for schizophrenia research: panel recommendations. Research resources. (1988) (4)
CHARACTERISTICS OF THE INHIBITION OF AROMATIC L-AMINO ACID DECARBOXYLASE BY ALPHA-METHYLAMINO ACIDS. (1963) (4)
Studies on tryptolines. (1976) (4)
Forms of opioid peptides circulating in human blood: investigation with multiple radioimmunoassays and radioreceptor assay. (1982) (4)
Deuterated biogenic amine metabolites: Preparation of ring‐deuterated 4‐hydroxy‐3‐methoxymandelic acid (1981) (4)
beta-Endorphin and schizophrenia. (1980) (4)
Introduction to the special section on the contribution of psychotherapy and pharmacotherapy research to national mental health care. (1996) (3)
Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats F. Maier, S. Davies, J.W. Grau, R.L. Jackson, D.H. Morrison, T. Moye, J. Madden, IV and J.D. Barchas, J. comp. physiol. Psychol., 94 (1980) 1172–1183 (1981) (3)
Prospects for the evaluation of endorphins as psychotropic agents. (1979) (3)
14CO2 elimination from (14C)tryptophan and (14C)tyrosine in human sleep and wakefulness. (1973) (3)
The imperative for research on severe mental disorders. (1994) (3)
Dephosphorylation of purified brain tyrosine hydroxylase by rat striatal extracts (1983) (3)
Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. (2016) (3)
Physiological Sociology. Endocrine Correlates of Status Behaviors (1975) (3)
Stimulation of rat striatal tyrosine hydroxylase by phospholipids and adenosine-3',5'-monophosphate. (1976) (3)
Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder (2022) (3)
Historical Perspectives on Modern Psychiatry (2007) (3)
Genetic aspects of the synthesis of catecholamines in the adrenal medulla (1975) (3)
CSF probenecid and biogenic amines. (1984) (3)
Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion (2004) (3)
Toxicity of 5-hydroxytryptoline in rats. (1978) (3)
CATECHOLAMINE MECHANISMS: THEIR PRESUMPTIVE ROLE IN THE GENERATION OF REM SLEEP PGO WAVES (1974) (3)
Delayed increase of adrenal TH adn PNMT activities following cold stress in the mouse. (1975) (3)
Effects of chronic melatonin and saline injections on pituitary adrenal secretion (1969) (2)
Cerebrospinal fluid monoamine metabolites in narcolepsy: Reanalysis (1989) (2)
METABOLISM OF D-VALINE BY STREPTOMYCES ANTIBIOTICUS: ISOLATION OF N-SUCCINYL-D-VALINE. (1964) (2)
Studies related to the clinical use of opioid agonists and antagonists (1981) (2)
MEASUREMENT OF MET-ENKEPHALIN(ARG6, PHE7) IN RAT BRAIN BY SPECIFIC RADIOIMMUNOASSAY DIRECTED AT METHIONINE SULPHOXIDE ENKEPHALIN (ARG6, PHE7) (1981) (2)
Tritiated ethylketocyclazocine binding in rat brain: differential distribution of binding sites across brain regions. (1982) (2)
Pharmacokinetic Studies with Choline Chloride: A Preliminary Report (1979) (2)
Some issues for the new director of NIMH. (1994) (2)
Some Thoughts About the Archives (1995) (2)
Sociophysiology 25 years ago: early perspectives of an emerging discipline now part of social neuroscience (2011) (2)
Alpha-N-acetyl beta-endorphins in the pituitary: immunohistochemical localization using antibodies raised against dynorphin(1-13). (1981) (2)
5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administration (1976) (2)
Determination of tryptamine in rat brain by gas chromatography-mass spectrometry. (1988) (2)
Neuroregulators and psychiatric disorders : proceedings of a conference on neuroregulators and hypotheses of psychiatric disorders held at the Asilomar Conference Center, Pacific Grove, California, January 13-16, 1976 (1977) (2)
The contribution of psychotherapy and pharmacotherapy research to national mental health care. Introduction to the special series. (1996) (2)
Catecholamines in the pituitary: origin and fate. (1973) (2)
Correction: Probenecid monoamine test (1988) (1)
TREATMENT OF HYPERPHENYLALANINEMIA V WITH TETRAHYDROBIOPTERIN (BH4) AND NEUROTRANSMITTER (NT) PRECURSORS (1984) (1)
MULTIPLE OPIATE BINDING SITES IN RAT BRAIN: DIFFERENTIAL DISPLACEMENT OF 3H-NALOXONE BINDING BY DIFFERENT OPIATE LIGANDS (1980) (1)
An approach to the molecular biology of opiate tolerance: identification of opiate-regulated transcripts. (1991) (1)
EMERGENT SOCIAL BEHAVIOR AND HORMONAL ACTIVITY (1979) (1)
DIFFERENTIAL INTERACTIONS OF DYNORPHIN(1–13), β-ENDORPHIN, AND ENKEPHALIN-RELATED PEPTIDES AT μ AND δ SITES IN DIFFERENT BRAIN REGIONS (1981) (1)
Somatomedin Gene Expression (1987) (1)
Molecular neurobiology--a conference sponsored by the NIMH. (1988) (1)
Brain stem norepinephrine: Behavioural and biochemical differentiation of responses to footshock in rats (1974) (1)
The Madness Within Us: Schizophrenia as a Neuronal Process (2010) (1)
Catecholamines II (1989) (1)
Nicotine dependence: perspectives on a new guideline from APA. (1996) (1)
Biochemical Aspects of Anxiety (1999) (1)
Studies on the elevation of phenylethanolamine N-methyl transferase (PNMT) activity in the rat following physiologic manipulation. (1969) (1)
Serotonin and pituitary-adrenal function. [in rat under stress] (1974) (1)
Neuropeptides in behavior and psychiatric syndromes: an overview. (1986) (1)
Endocrine, Circadian and Behavioral Processes in Mood Disorders (1999) (1)
THE EFFECT OF ACUTE ADMINISTRATION OF MORPHINE AND OPIATE ANTAGONISTS ON THE INDOLE CONTENT OF THE RAT PINEAL GLAND (1980) (1)
LCEC analysis of indoles in biological tissues. (1982) (1)
DETECTION OF α-N-ACETYL β-ENDORPHINS IN PITUITARY BY SPECIFIC ANTIBODIES (1981) (1)
PHYSOSTIGMINE INDUCED ALTERATIONS OF DOPAMINE METABOLITES IN CSF OF NORMAL SUBJECTS (1979) (1)
Studies related to the metabolic processing of endogenous opioids (1981) (1)
Psychiatric and neurologic aspects of war : published in cooperation with the Association for Research in Nervous and Mental Disease (2010) (1)
PHOSPHORYLATION OF ENDOGENOUS β-LIPOTROPIN AND OTHER PEPTIDES BY SLICES OF PITUITARY, ADULT BRAIN AND NEONATE BRAIN OF THE RAT (1980) (1)
Enkephalin-like material in normal human CSF: measurement and levels H. Akil, S.J. Watson, S. Sullivan and J.D. Barchas, Life Sci., 23 (1978) 121–126 (1979) (1)
Genetic studies of aggression in inbred mouse strains [proceedings]. (1977) (1)
Corrections to a 1980 article on CSF monoamine metabolites. (1989) (1)
DISCRETE REGIONAL DISTRIBUTION FOR ENKEPHALINASE AND AMINOPEPTIDASE IN MICRODISSECTED RAT BRAIN (1981) (1)
Brain dopamine-beta-hydroxylase activity in vivo: pharmacological, endocrinological, and psychological implications for adaptation. (1975) (1)
Methylxanthine-facilitated shock-induced aggression in the rat (1978) (1)
The Regulation of Tyrosine Hydroxylase Activity by Phosphorylation (1982) (1)
1107 – SIMULATANEOUS MICRO-DETERMINATION OF INDOLE- AND CATECHOLAMINES IN SMALL BRAIN REGIONS USING A WEAK CATION EXCHANGE RESIN (1977) (0)
Reviewers for 1999 (1999) (0)
A thanks to the ARCHIVES community: our farewell editorial. (2001) (0)
β-LIPOTROPIN, CORTICOTROPIN AND β-ENDORPHIN: PHOSPHORYLATION BY CYCLIC AMP-DEPENDENT AND INDEPENDENT PROTEIN KINASES (1980) (0)
Enkephalin Containing Peptides in Human Blood (1981) (0)
BEHAVIORAL NEUROCHEMISTRY--EXPANDING PERSPECTIVES (1979) (0)
2013 Daniel H. Efron Research Award (2012) (0)
Patent Number : ( 45 ) Date of Patent : 5 , 168 , 038 Dec . 1 , 1992 Acid Hybridization " A practical Approach (2017) (0)
Optimization : A Result or a Mechanism ? (2005) (0)
Reviewers for 2000 (2000) (0)
Li+ and Anticonvulsants are Important in the Treatment of Mood Disorders (1999) (0)
Brain and Adrenal Metabolic Responses to Stress (The Role of Brain Catecholamines in Regulation of Response to Stress). (1982) (0)
Overexpression of Cancer- and Neurotransmitter-Associated Genes in the Nucleus Accumbens of Smokers (2022) (0)
A mathematical model of central dopaminergic transmission and the dopamine hypothesis of schizophrenia (1981) (0)
Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia (2023) (0)
Electroconvulsive Therapy: A Potent Therapy for Major Depressive Disorder (2014) (0)
Solubility of lithium salts in organic solvents. (1985) (0)
Genetic control of catecholamine synthesis (1973) (0)
7 – Studies of β-Endorphin in Patients with Mental Illness (1981) (0)
B 3-Lipotropin : Localization of cells and axons in rat brain by immunocytochemistry ( opiate peptides / endorphin / corticotropin / anatomy ) (0)
Synthetic N-dimethyl beta-endorphin, a stabilized opioid peptide. (1981) (0)
690 – 5-HYDROXYTRYPTOLINE: PHARMACOLOGICAL ACTIONS (1977) (0)
Introduction for Affective Disorders and Traumatic Brain Injury: Qatar Clinical Neuroscience Conference (2015) (0)
Bombesin, IsPresent inHuman Neuroendocrine LungTumors (1984) (0)
Acetylcholine Mechanisms Have Been Implicated in Mood Disorders (1999) (0)
The effects of alcohol on cyclic AMP in mouse brain (1976) (0)
Instrumentation for study of neuroregulatory agents and behavior. (1969) (0)
THE ROLE OF ENDORPHINS IN SCHIZOPHRENIA: CLINICAL STUDIES (1981) (0)
Perspectives in psychopharmacology: proceedings/Earl Usdin neuroscience research symposium, 1984, Irvine, CA, USA (1988) (0)
Reviewers Who Completed a Review During 2001 (2001) (0)
Perspectives in behavioural neurochemistry. (1977) (0)
1434 – 5-MTHF MEDIATED FORMATION OF TRYPTOLINES (TETRAHYDRO-β-CARBOLINES) BY HUMAN BRAIN (1977) (0)
Receptor Hypotheses of Mood Disorders (1999) (0)
Large Common Mitochondrial DNA Deletions Are Associated with a Mitochondrial SNP T14798C Near the 3′ Breakpoints (2022) (0)
Sleep mechanisms: Sleep deprivation and detection of changing levels of consciousness (1972) (0)
mtDNA copy number, mtDNA total somatic deletions, Complex I activity, synapse number and synaptic mitochondria number are altered in schizophrenia and bipolar disorder (2022) (0)
An Accessible Review of Emerging Issues in Psychopharmacology. (1988) (0)
EFFECTS OF ACUTE AND CHRONIC STRESS ON RAT BRAIN EPINEPHRINE (1984) (0)
Memorandum from Jack Barchas to Joshua Lederberg (1973) (0)
EP INEPHRINE FORMING ENZYME IN HUMAN BRAIN (1979) (0)
Depression and Manic-Depressive Illness: Two Major Categories of Mood Disorders (1999) (0)
Privileged communications. The effect of California's new evidence code as it concerns physicians and psychotherapists. (1966) (0)
The Council on Research (1990) (0)
How Much Food from the Sea? (2005) (0)
Physostigmine Related Changes in Cerebrospinal Fluid Neurotransmitter Metabolites in Man (1979) (0)
Phosphorylation of beta-lipotropin, beta-endorphin, corticotropin, and parathyroid hormone: a potential control for peptide processing. (1980) (0)
The High Cost of Cutting Back on Research Funding (1985) (0)
Background and acknowledgments (2010) (0)
Reports on past meetings (1982) (0)
Neurotransmission-Related Gene Expression in the Frontal Pole (Brodmann Area 10) is Altered in Subjects with Bipolar Disorder and Schizophrenia (2022) (0)
1425 – EFFECTS OF VERATRIDINE AND DIBUTYRYL CYCLIC AMP ON DOPAMINE SYNTHESIS AND RELEASE IN RAT BRAIN STRIATAL SYNAPTOSOMES (1977) (0)
Biological Concomitants of Mood Disorders (1999) (0)
Child and adolescent mental disorders and the search for an NIMH director. Quo Vadis? (1995) (0)
PROCEDE DE SUPPRESSION DE L'APPETIT PAR ADMINISTRATION DE DERIVES DE TETRAHYDRO-β-CARBOLINE (1990) (0)
Trait Locus Brain HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders. (2016) (0)
Studies of beta-endorphin in psychiatric patients. (1982) (0)
Immunohistochemical distribution of a-neo-endorphin / dynorphin neuronal systems in rat brain : Evidence for colocalization ( opioid peptide neurons / brain distribution / immunofluorescence ) (2003) (0)
Probenecid monoamine test [correction]. (1988) (0)
Neuroregulators and Stress, 1979 - 1986. (1986) (0)
193 – COMPARISON OF THE MECHANISMS OF DOPAMINE AND APQMORPHINE-INDUCED INHIBITION OF DOPAMINE SYNTHESIS IN RAT BRAIN STRIATAL SYNAPTOSOMES (1977) (0)
442 – MULTIPLE OPIOID SYSTEMS IN BRAIN: ENKEPHALINS AND β-ENDORPHIN/3-LPH/ACTH (1978) (0)
Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder (2018) (0)
Biotechnology in clinical medicine (1987) (0)
Post-mortem molecular profiling of three psychiatric disorders (2017) (0)
CSF monamine metabolites in movement disorders and normal aging. (1985) (0)
Roland D. Ciaranello, MD February 27, 1943, to December 14, 1994 (1995) (0)
Clonidine: basic and clinical perspectives. (1982) (0)
Genetics of human aggression. (1977) (0)

This paper list is powered by the following services:

Other Resources About Jack Barchas

en.wikipedia.org

What Schools Are Affiliated With Jack Barchas?

Jack Barchas is affiliated with the following schools:

Jack Barchas's Academic­Influence.com Rankings